Background and Aims: The aim of the present study was to investigate the relationship between visceral fat area (VFA), estimated by bioimpedance, and cardiovascular risk factors independent of BMI and waist circumference in a cohort of Romanian patients. Material and Methods: This was a cross-sectional study, in which were collected data from 751 patients ≥18 years of age from Cluj-Napoca. Anthropometric, biochemistry, body composition and medical history parameters were recorded from patients’ files. Results: Compared with the participants with VFA <100 cm2, those with VFA ≥100 cm2 had significantly worse levels of the laboratory parameters describing the glycemic metabolism, lipid metabolism and liver functions (p <0.05 for all). A higher percentage of participants with VFA ≥100 cm2 had diabetes, obesity, hypertension, hypertriglyceridemia and hypo-HDL cholesterolemia (p <0.05 for all). VFA was correlated with systolic and diastolic blood pressure, total and LDL-cholesterol levels, triglycerides, ALT, previous diagnosis of diabetes, hypertriglyceridemia and hypo-HDL cholesterolemia independent of BMI and waist circumference. Conclusions: Among this cohort of Romanian adults, an increasing level of visceral adiposity was correlated with worse lipid and glucose metabolism parameters as well as with increased levels of ALT, which probably reflects liver fat deposition.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. World Health Organization. The world health report 2002: Reducing risks, promoting healthy life. World Health Organization, Geneva, 2002. Accessed in September 2015 at: http://www.who.int/whr/2002/en/whr02_en.pdf?ua=1
2. World Cancer Research Fund/American Institute for Cancer Research. Policy and action for cancer prevention. Food, nutrition, and physical activity: a global perspective. AICR, Washington DC, 2009. Accessed in September 2015 at: http://www.dietandcancerreport.org/cancer_resource_center/downloads/chapters/pr/Introductory%20pages.pdf.
3. World Health Organization. Global status report on noncommunicable diseases 2014. Attaining the nine global noncommunicable diseases targets; a shared responsibility. World Health Organization, Geneva, 2014.Accessed in September 2015 at: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1.
4. Roman G, Bala C, Creteanu G, et al. Obesity and Health-Related Lifestyle Factors in the General Population in Romania: a Cross Sectional Study. Acta Endo (Buc) 11: 64-72, 2015.
5. Moța M, Moța E, Popa SG, et al. The national study on the prevalence of diabetes mellitus, prediabetes, overweight, obesity, dyslipidemia, hyperuricemia and chronic kidney disease in Romania - Final results. Acta Diabetologica Romana 40: 24-26, 2014. (abstract)
6. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organization, Geneva, 2004.
7. World Health Organization. Obesity-preventing and managing the global epidemic. Report of a WHO Consultation. World Health Organization, Geneva, 2000.
8. Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong ND. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int J Obesity 33: 239-248, 2009.
9. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS. Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 32: 1068-1075, 2005.
10. Lemieux S, Prud’homme D, Moorjani S, et al. Do elevated levels of abdominal visceral adipose tissue contribute to age related differences in plasma lipoprotein concentrations in men? Atherosclerosis 118: 155-164, 1995.
11. Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity and the risk of impaired glucose tolerance. Diabetes Care 26: 650-655, 2003.
12. Gallagher D, Kelley DE, Yim JE, et al. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 89: 807-814, 2009.
13. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444: 881, 2006.
14. Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. Part I: Heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes & Metabolism 34: 317-327, 2008.
15. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL. Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 30: 1652, 2007.
16. van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Visser M. Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry. Br J Nutr 70: 47-58, 1993.
17. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51: 1106-1112, 1990.
18. Bovet P, Arlabosse T, Viswanathan B, Myers G. Association between obesity indices and cardiovascular risk factors in late adolescence in the Seychelles. BMC Pediatr 12: 176, 2012.
19. Mahanta BN, Mahanta TG. Clinical profile of persons with family history of diabetes mellitus with special reference to body fat percentage. J Assoc Physicians India 57: 703-705, 2009.
20. Marques-Vidal P, Pécoud A, Hayoz D, et al. Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation. Nutr Metab Cardiovasc Dis 20: 669-675, 2010.
21. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645, 2009.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
23. Vazquez G, Duval S, Jacobs DR, Jr, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 29: 115-128, 2007.
24. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51: 679-689, 2010.
25. Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation 126: 1301-1313, 2012.
26. Guebre-Egziabher F, Alix PM, Koppe L, et al. Ectopic lipid accumulation: a potential cause for metabolic disturbances and a contributor to the alteration of kidney function. Biochimie 95: 1971-1979, 2013.
27. Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34: 1055-1058, 1985.
28. Peppa M, Koliaki C, Papaefstathiou A, et al. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women. Obesity (Silver Spring) 21: 1807-1814, 2013.
29. Castro AV, Kolka CM, Kim SP, Bergman RN. Obesity, insulin resistance and comorbidities? Mechanisms of association. Arq Bras Endocrinol Metabol 58: 600-609, 2014.
30. Samaras K, Botelho NK, Chisholm DJ, Lord RV. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity (Silver Spring) 18: 884-889, 2010.
31. Li X, Katashima M, Yasumasu T, Li KJ. Visceral fat area, waist circumference and metabolic risk factors in abdominally obese Chinese adults. Biomed Environ Sci 25: 141-148, 2012.
32. Onat A. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obesity 28: 1018-1025, 2004.
33. Turcato E, Bosello O, Di Francesco V, et al. Waist circumference and abdominal sagittal diameter as surrogates of body fat distribution in the elderly: their relation with cardiovascular risk factors. Int J Obes Relat Metab Disord 24: 1005-1010, 2000.
34. Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 284: E1065-E1071, 2003.
35. Stranges S, Dorn JM, Muti P, et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 39: 754-763, 2004.
36. Ruhl CE, Everhart JE. Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology 138: 1346-1356, 2010.